Galmed Pharmaceuticals Ltd. (EOCN) Form 10-K Annual Reports
Galmed Pharmaceuticals Ltd. (EOCN) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: EOCN
CIK: 1595353
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: L3
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Brightman Almagor Zohar & Co.
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerDavid Gottlieb
Audit LocationTel Aviv, Israel
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 6-K | 2026-09-09 | 2026-09-09 | 6-K | 0001493152-26-041872 | View SEC Doc Filr Page |
| 6-K | 2026-09-08 | 2026-09-08 | 6-K | 0001493152-26-041656 | View SEC Doc Filr Page |
| EFFECT | 2026-09-03 | — | EFFECT Filing | 9999999995-26-002874 | View SEC Doc Filr Page |
| 6-K | 2026-09-03 | 2026-09-03 | 6-K | 0001493152-26-041357 | View SEC Doc Filr Page |
| POS AM | 2026-09-02 | — | POS AM | 0001493152-26-041245 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-06-30 | 6-K | 0001493152-26-041239 | View SEC Doc Filr Page |
| 6-K | 2026-09-02 | 2026-09-02 | 6-K | 0001493152-26-041231 | View SEC Doc Filr Page |
| 6-K/A | 2026-08-19 | 2026-07-22 | 6-K/A | 0001493152-26-039207 | View SEC Doc Filr Page |
| 6-K | 2026-08-19 | 2026-08-19 | 6-K | 0001493152-26-039109 | View SEC Doc Filr Page |
| 6-K | 2026-08-17 | 2026-08-17 | 6-K | 0001493152-26-038663 | View SEC Doc Filr Page |
| 6-K | 2026-08-14 | 2026-08-14 | 6-K | 0001493152-26-038436 | View SEC Doc Filr Page |
| 6-K | 2026-07-31 | 2026-07-31 | 6-K | 0001493152-26-035621 | View SEC Doc Filr Page |
| 6-K | 2026-07-29 | 2026-07-29 | 6-K | 0001493152-26-035185 | View SEC Doc Filr Page |
| 6-K | 2026-07-28 | 2026-07-28 | 6-K | 0001493152-26-034933 | View SEC Doc Filr Page |
| 6-K | 2026-07-22 | 2026-07-22 | 6-K | 0001493152-26-034237 | View SEC Doc Filr Page |
| 6-K | 2026-07-16 | 2026-07-16 | 6-K | 0001493152-26-033451 | View SEC Doc Filr Page |
| 6-K | 2026-07-08 | 2026-07-08 | 6-K | 0001493152-26-032504 | View SEC Doc Filr Page |
| 424B3 | 2026-06-22 | — | 424B3 | 0001493152-26-029481 | View SEC Doc Filr Page |
| 6-K | 2026-06-22 | 2026-06-22 | 6-K | 0001493152-26-029478 | View SEC Doc Filr Page |
| POS EX | 2026-06-08 | — | POS EX | 0001493152-26-027646 | View SEC Doc Filr Page |
| 424B3 | 2026-06-08 | — | 424B3 | 0001493152-26-027645 | View SEC Doc Filr Page |
| 6-K | 2026-06-08 | 2026-06-08 | 6-K | 0001493152-26-027640 | View SEC Doc Filr Page |
| 6-K | 2026-06-02 | 2026-06-02 | 6-K | 0001493152-26-026756 | View SEC Doc Filr Page |
| 6-K | 2026-05-14 | 2026-05-14 | 6-K | 0001493152-26-022873 | View SEC Doc Filr Page |
| 6-K | 2026-05-06 | 2026-05-06 | 6-K | 0001493152-26-021404 | View SEC Doc Filr Page |